Previous 10 | Next 10 |
2024-07-15 11:10:00 ET Summary TimesSquare Capital U.S. Small Cap Growth portfolio outperformed the Russell 2000® Growth Index in the second quarter. The second quarter was good for the equity markets—provided one only owned a handful of the largest, most growthy, U.S....
AtriCure, Inc. ( Nasdaq: ATRC ), a leading innovator in surgical treatments and therapies for atrial fibrillation (Afib), left atrial appendage (LAA) management, and post-operative pain management, today announced that it will release its second quarter 2024 financial results on Tuesday, Ju...
2024-06-28 06:50:00 ET InvestorPlace - Stock Market News, Stock Advice & Trading Tips Low-priced stocks to buy with the potential to double within the next year or so have inherent appeal for investors. Individual shares are affordable making it relatively easy to establish a st...
2024-06-25 10:40:00 ET Summary TimesSquare Capital Management, LLC is a fundamental research-oriented growth equity investment management firm specializing in growth equity strategies for institutional investors. TimesSquare uses a well-established team approach to growth investing th...
2024-06-21 08:00:00 ET Summary TimesSquare Capital Management, LLC is a fundamental research-oriented growth equity investment management firm specializing in growth equity strategies for institutional investors. TimesSquare uses a well-established team approach to growth investing th...
2024-06-19 22:06:00 ET Stock Traders Daily has produced this trading report using a proprietary method. This methodology seeks to optimize the entry and exit levels to maximize results and limit risk, and it is also applied to Index options, ETFs, and futures for our subscribers. This...
2024-06-18 11:06:42 ET More on AtriCure AtriCure, Inc. (ATRC) Q1 2024 Earnings Call Transcript AtriCure Q1 2024 Earnings Preview AtriCure upgraded at Oppenheimer on valuation Seeking Alpha’s Quant Rating on AtriCure Historical earnings data for...
2024-05-19 07:32:00 ET Stock Traders Daily has produced this trading report using a proprietary method. This methodology seeks to optimize the entry and exit levels to maximize results and limit risk, and it is also applied to Index options, ETFs, and futures for our subscribers. This...
2024-05-16 16:41:26 ET Summary We recap Q1 developments from Pulse Biosciences, Inc. The FDA has cleared the company's percutaneous electrode system, while the surgical clamp device for cardiac indications is still in the preclinical trial phase. Pulse Biosciences is making pr...
AtriCure, Inc. ( Nasdaq: ATRC ), a leading innovator in surgical treatments and therapies for atrial fibrillation (Afib), left atrial appendage (LAA) management, and post-operative pain management, today announced that the company will be participating in the upcoming Leerink Partners Healt...
News, Short Squeeze, Breakout and More Instantly...
2024-07-31 08:00:12 ET Rick Wise from Stifel Nicolaus issued a price target of $26.00 for ATRC on 2024-07-31 06:57:00. The adjusted price target was set to $26.00. At the time of the announcement, ATRC was trading at $22. The overall price target consensus is at $56.00 w...
Worldwide revenue of $116.3 million – an increase of 15.2% year over year Positive cash flow generation of $8.1 million in second quarter 2024 AtriCure, Inc. ( Nasdaq: ATRC ), a leading innovator in surgical treatments and therapies for atrial fibrillation (Afib), l...
CFSB Bancorp Inc. (CFSB) is expected to report for Q4 2024 Big 5 Sporting Goods Corporation (BGFV) is expected to report $-0.48 for Q2 2024 Canadian Pacific Kansas City Limited (CP) is expected to report $0.74 for Q2 2024 Captivision Inc. (CAPT) is expected to report for quarter end 2...